Cochlear Limited provided earnings guidance for the fiscal year 2024. For the year, the company expects net profit to be between $355 million to $375 million and anticipates revenue growth.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
334.4 AUD | +0.18% | +3.11% | +12.25% |
Jul. 16 | Genetic Technologies Names CFO | MT |
May. 29 | UK’s Competition Regulator Closes Cochlear-Demant Deal | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.25% | 14.9B | |
-15.19% | 20.79B | |
-1.17% | 18.25B | |
+4.19% | 1.79B | |
-31.27% | 1.73B | |
+0.44% | 1.26B | |
-6.05% | 490M | |
0.00% | 345M | |
+91.59% | 221M | |
+16.54% | 99.35M |
- Stock Market
- Equities
- COH Stock
- News Cochlear Limited
- Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2024